Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...
An interprofessional team at Children's Hospital of Philadelphia is transforming CHOP's approach to fetal medicine through a ...
Along with the joint spinoff with a venture-capital firm, the Skokie-based carbon recycling company announced an interim CFO.
Debut, the biotech beauty leader, announced today the launch of BeautyORBâ„¢, an AI-powered innovation engine that provides a ...
Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of ...
Management will also be available for DURHAM, N.C., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally ...
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
A Platform For Animal Cell Technology West European biotechnology companies are getting together to establish a mechanism to ensure that they reap the benefits of European Community-funded research on ...
BioChatter can be adapted to specific research areas to pull data from biomedical databases and literature. Further, ...
Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...
Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform. | Neomorph is ...
Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...